Matteo Lambertini, MD PhD· @matteolambe · X·· 1 天前评分70
正文 · 原文
Oral abstract #BreastCancer session at #ESMO26: updated 15-y results from @NSABPFoundation NSABP B42 trial on extended #letrozole in post menopausal women with HR+ disease
@OncoAlert @myESMO
609 浏览 · 17 赞 · 11 转发 · 0 回复
来源：Matteo Lambertini, MD PhD · x.com